Tracked deals
8
8 tracked deals across 2021-2022.
Operating Company
Healthcare
CenExel Clinical Research
Salt Lake City, Utah, United States
CenExel is an integrated, wholly owned, nationwide clinical research site network comprised of Centers of Excellence that supports complex clinical trial outcomes with scientific expertise, operational efficiencies, and patient engagement (Phase I–IV across multiple therapeutic areas, with emphasis on CNS/neurology/psychiatry).
- Focus Areas
- Clinical research site network, Clinical trial services (Phase I–IV), Centers of Excellence
- Website
- cenexel.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
7 buyout · 1 divestiture
CenExel Clinical Research Acquisition Volume by Year
Last 2 years
Supporting Data
Recent Transactions
-
- Buyer
- CenExel Clinical Research, Inc. (CenExel)
- Target
- Apex Innovative Sciences, Inc., Collaborative Neuroscience Research (CNS), Hassman Research Institute (HRI)
- Seller
- Bison Capital Partners V, LP
- Industry
- Healthcare Services
- Location
- United States
- Type
- Divestiture
CenExel Clinical Research has acquired Apex Innovative Sciences, Inc. from Bison Capital Partners V, LP. The transaction adds Apex’s CNS-focused clinical research sites (including Collaborative Neuroscience Research and Hassman Research Institute) — five centers across California and New Jersey with substantial early‑phase and inpatient capacity — expanding CenExel’s neuroscience capabilities and geographic footprint.
-
May 3, 2022
- Buyer
- CenExel
- Target
- iResearch
- Seller
- iResearch (co-founders Heather Beitz and Sara Castle)
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Type
- Buyout
CenExel, a Salt Lake City–based clinical research site network, acquired iResearch, a multi-specialty clinical research site with locations in Decatur and Savannah, Georgia. The deal strengthens CenExel's CNS (psychiatry and neurology) and dermatology trial capabilities while expanding its patient reach in the Atlanta metro and throughout Georgia.
-
February 22, 2022
- Buyer
- CenExel Clinical Research, Inc.
- Target
- CTSdatabase
- Industry
- Healthcare Services
- Location
- California, United States
- Type
- Buyout
CenExel Clinical Research has acquired CTSdatabase, a global duplicate-subject detection and clinical trial registry led by Dr. Thomas M. Shiovitz. The acquisition integrates CTSdatabase's subject-detection capabilities into CenExel's site network to improve data quality across clinical trials while CTSdatabase will continue to operate independently and support external sponsors and CROs.
-
- Buyer
- CenExel Clinical Research, Inc.
- Target
- Rocky Mountain Movement Disorders Center (CenExel RMCR)
- Seller
- Rocky Mountain Movement Disorders Center, Dr. Rajeev Kumar
- Industry
- Healthcare Services
- Location
- Colorado, United States
- Type
- Buyout
CenExel Clinical Research, Inc. acquired the clinical research site operations of Rocky Mountain Movement Disorders Center (now CenExel RMCR), expanding CenExel's neurology/CNS trial capabilities and site network. Objective, Investment Banking & Valuation acted as exclusive sell-side advisor to Rocky Mountain Movement Disorders Center and the transaction will allow the center to leverage CenExel's centralized processes and network.
-
January 10, 2022
- Buyer
- CenExel Clinical Research, Inc.
- Target
- California Neuroscience Research
- Industry
- Healthcare Services
- Location
- California, United States
- Type
- Buyout
CenExel Clinical Research, a Salt Lake City–based clinical research site network, has acquired California Neuroscience Research, a Los Angeles area neurology and psychiatry clinical research facility led by Dr. Tom Shiovitz. The acquisition strengthens CenExel's central nervous system (CNS) trial capabilities and expands its patient reach in the Los Angeles market.
-
- Buyer
- CenExel Clinical Research, Inc.
- Target
- Advanced Memory Research Institute
- Industry
- Healthcare Services
- Location
- United States
- Type
- Buyout
CenExel Clinical Research, Inc. has acquired Advanced Memory Research Institute (CenExel AMRI), the largest Alzheimer's Disease clinical research site in the U.S. Northeast. The deal expands CenExel's CNS and Alzheimer's trial capabilities by integrating AMRI into its Centers of Excellence network; Provident Healthcare Partners served as exclusive sell-side financial advisor.
-
August 4, 2021
- Buyer
- CenExel Clinical Research, Inc.
- Target
- ForCare Clinical Research
- Industry
- Healthcare Services
- Location
- Florida, United States
- Type
- Buyout
CenExel Clinical Research has acquired Tampa-based ForCare Clinical Research, adding a dermatology- and immunology-focused clinical research site to its Centers of Excellence network. The addition strengthens CenExel's capabilities to conduct Phase I–IV trials across dermatology, immunology and other therapeutic areas and will integrate ForCare into CenExel's centralized operations and quality systems. Provident Healthcare Partners served as exclusive sell-side financial advisor to ForCare in the transaction.
-
March 9, 2021
- Buyer
- CenExel Clinical Research, Inc.
- Target
- CITrials
- Industry
- Healthcare Services
- Location
- California, United States
- Type
- Buyout
CenExel Clinical Research, a U.S.-based network of clinical research sites, has acquired CITrials, a Southern California clinical research firm operating three sites serving Los Angeles, Orange, and Riverside/San Bernardino counties. The acquisition expands CenExel's capacity and capabilities in psychiatric and neurological (CNS) research and enables greater integration with its other Southern California operations.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
8 tracked deals by CenExel Clinical Research.
Acquisitions in California
3 tracked deals by CenExel Clinical Research.
Acquisitions in Colorado
1 tracked deal by CenExel Clinical Research.
Acquisitions in Florida
1 tracked deal by CenExel Clinical Research.
Acquisitions in Georgia
1 tracked deal by CenExel Clinical Research.
Selling a company? Get in front of buyers like CenExel Clinical Research
Turn tracked acquisition activity into an outreach-ready buyer list.